Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
IV Bags Market: By Product Type, By Material Type, Ethylene Vinyl Acetate, Copolyester Ether), By Size, By Application, and Region Forecast 2019-2030
IV bags market size was valued at US$ 7,831.4 million in 2023 and is projected to reach US$ 14,782.2 million by 2030, growing at a CAGR of 9.5% from 2024-2030. In 2023, 35,140 million units were sold and are projected to grow at a CAGR of 5.7 % over the forecast years to reach 51,800 million units by 2030. Moreover, in the USA, US$ 1,799.5 million in 2023 and is projected to reach US$ 3,185.4 million by 2030, growing at a CAGR of 8.5% from 2024-2030. In 2023, 1,260 million units were sold and projected to grow at a CAGR of 3.8% over the forecast years.
The market is witnessing rapid growth thanks to the increasing chronic diseases and aged population, increased surgeries, and preference for single-use bags to prevent infection. World healthcare expenditures are on the rise; while WHO reports that the aged population of developing nations and the growing requirement for IV solutions is on the increase. There are also limitations in the market, which may impact the expansion, such factors include the disposal of disposable plastic bags creating an environmental issue, expensive production processes, the setting of tight regulations, and competition from alternative treatments, among others. Manufacturers respond by designing eco-friendly, biodegradable versions that are also supported by grants from the government, such as the recent U.S. $10 million grant for sustainable medical products. There is also room for growth in emerging markets, such as healthcare investments.
Technologies include multi-chamber bags and IV bags suitable for home use that the NIH, with a $400 million funding initiative in the US, supports. Other current trends in the market are PVC-free bags, ready-to-use solutions, and customized products which reflect the continuing modernization of environmental and operational efficiency demands. Outsourcing production is also the new trend, and in the US, it grows by 8% annually and supports IV bag supply chains worldwide.
The IV Bag Market size includes several companies, such as ICU Medical, Inc., Medline Industries, Inc., Kraton Corporation, Braun Melsungen AG, Otsuka Pharmaceutical Co. Ltd, Haemotronic S.p.A, Wipak Group, Fresenius SE & Co. KGaA, Polycine GmbH, and others.
By Product Type: The Single Chamber IV Bags segment dominates the market with maximum market shares within the product type classification. Single chamber bags are widely used within various IV therapies for hydration, electrolyte balancing, and generally for simple medication administration within healthcare settings. They are convenient to use and relatively cheaper and hence suitable for standard procedures, mostly within areas of resource constraints where multi-chamber bags might be regarded as unnecessary or relatively costlier. Single-chamber bags meet most of the simple requirements of everyday clinical work and for that reason are at the leading position in not only developed but also developing healthcare systems.
By Material: Based on material, the segment is dominated by Polyvinyl Chloride (PVC). PVC is traditionally used as it is strong and flexible. Additionally, the cost-effectiveness of PVC also makes it a reliable choice for most healthcare providers. Even though environmentally related concerns and increased regulatory scrutiny have sparked dissent in favor of PVC use, it will continue to dominate application spaces, especially in regions where polypropylene or ethylene vinyl acetate is more expensive.
By Size: The 500-1000 ml segment has the highest market share in terms of size. This is the appropriate size for intravenous hydration and nutrient administration for adult patients who need large volumes of fluids.
By Application: In terms of application, medications hold the largest share. IV bags, in this respect, play a crucial role in medication delivery across almost all kinds of treatment in hospitals, clinics, and home healthcare. The need for this segment increases with the increasing percentage of chronic diseases and the growing number of surgeries, making medication-based IV bags critical in various settings of healthcare.
Study Period
2024-2030Base Year
2023CAGR
9.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Intravenous therapy needs to be continued uninterruptedly for the treatment and hydration of chronic diseases like diabetes, cardiovascular disease, and cancer. According to the World Health Organization, by 2030, in developing nations, the incidence of chronic diseases will increase by nearly 70%. Such high disease burdens increase the demand, and demand for IV bags is also going to increase. These bags are crucial for fluid therapy, drug administration, and nutritional support. According to the United Nations, the elderly population worldwide is expected to increase by 2050 and reach double, to 1.5 billion. Elderly populations are more prone to diseases and require frequent IV treatments both in home care settings and hospitals, thus increasing the demand for IV bags. Better access to healthcare facilities and surging rates of both elective and emergency surgery have made surgical procedures prevalent around the world. According to the WHO, it is estimated that approximately 313 million surgeries take place every year worldwide. IV bags are utilized within surgery for fluid balance and drug delivery purposes, further fueling market demand. It has reduced the chance of contamination, and hence nosocomial infections have also decreased. In response, the incidence of hospitals taking up single-use IV bags is increasing more now, especially in developed countries where hygiene practices are very strict.
Traditionally, IV bags are manufactured out of polyvinyl chloride, a non-biodegradable material that creates a lot of medical waste. It has been estimated that 30 percent of all plastic wastes generated in health facilities come from disposable items and raise ecologic concerns. In this context, the tighter regulations the European Union introduces on the industry heighten concerns regarding greener practice or alternative materials that may exert competitive pressure on companies. The cost of creating high-quality, sterile IV bags is inherently prohibitive as it must pass stiff safety standards. Volatility in raw material prices, especially for PVC and other polymers, will impact the margins. This is rather a challenge for market growth, with countries being sensitive to the costs. Regulations concerning medical devices are stringent and differ from region to region. Meeting FDA standards in the US and the European Medicines Agency in the EU impacts the development cycle and often makes onboarding challenging and expensive for new entrants, thereby restricting the growth of this market. IV bags are also competitors of alternative drugs which are oral and topical medications. These are less invasive and easier to be dealt with in outpatient treatment, thus limiting the demand for IV solutions.
Investments are rising in green IV bags based on environmental awareness that includes plant-based plastics. In recent years, the U.S. government also granted $10 million to a sustainable medical solution promoting innovations in biodegradable IV bags. Healthcare investments have been on an upward trajectory in emerging economies, such as India, China, and Brazil, over recent years. Health care expenses in India increased by 137% in the last decade, and so did the IV bag manufacturers reap the fertile opportunities provided by the birth of an expanded healthcare demand. The production of multi-chamber IV bags, as well as those with better temperature controls, is now made possible by advances in technology to effectively enhance treatment. Government-sponsored research grants are quite crucial, especially for the EU. The home health sector expansion arises from healthcare systems that turn on demand with a cost-effective, patient-centered care system. U.S. In 2023, the National Institutes of Health has allocated more than $400 million to home health solutions. Income funds that are received by the institutes increase demand for IV bags that are intended to be used in the home.
Due to greater consciousness about the ills of PVC, brought along by chemical leaching, alternative alternatives for safer options are in play. The REACH regulation in Europe has catalyzed this; the regulation bans harmful chemicals, increasing demand for PVC-free IV bags. Ready-to-use IV solutions decrease in-hospital preparation, leading to enhancements in safety and efficiency. The adoption of ready-to-use IV bags is increasing in Europe and the US, with healthcare institutions striving for optimal operational efficiency. Market data show an adoption level that is increasing by 20% over the last five years. Customized IV solutions, prepared to the specific needs of each patient in particular, are increasingly becoming popular, especially for complex cases. Such customization is very common in developed countries with good healthcare infrastructure, prompted by personalized medicine needs. Hospitals and other healthcare service providers are outsourcing their IV bag production to specialized companies to cut down costs and mainly focus on providing more primary care services. According to the research, the U.S. has an annual growth of 8% in the outsourcing of medical products.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 7,831.4 million |
Market Size in 2030 |
US$ 14,782.2 million |
Market CAGR |
9.5% |
By Product Type |
|
By Material Type |
|
By Size |
|
By Application |
|
By Region |
|
Download Free Sample Report
The global iv bags market size was valued at US$ 7,831.4 million in 2023 and is projected to grow at a significant CAGR of 9.5% from 2024-2030.
ICU Medical, Inc., Medline Industries, Inc., Kraton Corporation, Braun Melsungen AG, Hospira Inc., Otsuka Pharmaceutical Co. Ltd.
Asia Pacific is the fastest-growing region for the IV Bags Market
• Growing Prevalence of Chronic Diseases
• Aging Population
• Rise in Surgical Procedures
• Shift Towards Single-Use and Disposable IV Bags
• Shift Towards PVC-Free IV Bags
• Growth in Ready-to-Use IV Bags
• Focus on Customized IV Bag Solutions
• Rise in Outsourcing IV Bag Production
1. Executive Summary |
2. Global IV Bags Market Introduction |
2.1.Global IV Bags Market - Taxonomy |
2.2.Global IV Bags Market - Definitions |
2.2.1.Product Type |
2.2.2.Material Type |
2.2.3.Size |
2.2.4.Application |
2.2.5.Region |
3. Global IV Bags Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global IV Bags Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global IV Bags Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Single Chamber IV Bags |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Multi-Chamber IV Bags |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global IV Bags Market By Material Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Polypropylene |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Polyvinylchloride (PVC) |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Ethylene Vinyl Acetate |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Copolyester Ether |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global IV Bags Market By Size, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. 500-1000 ml |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. 250-500 ml |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Up to 250 ml |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global IV Bags Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Blood Storage |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Blood Transfusions |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Medications |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Electrolyte Imbalance |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global IV Bags Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America IV Bags Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Single Chamber IV Bags |
10.1.2.Multi-Chamber IV Bags |
10.2. Material Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Polypropylene |
10.2.2.Polyvinylchloride (PVC) |
10.2.3.Ethylene Vinyl Acetate |
10.2.4.Copolyester Ether |
10.3. Size Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.500-1000 ml |
10.3.2.250-500 ml |
10.3.3.Up to 250 ml |
10.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Blood Storage |
10.4.2.Blood Transfusions |
10.4.3.Medications |
10.4.4.Electrolyte Imbalance |
10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe IV Bags Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Single Chamber IV Bags |
11.1.2.Multi-Chamber IV Bags |
11.2. Material Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Polypropylene |
11.2.2.Polyvinylchloride (PVC) |
11.2.3.Ethylene Vinyl Acetate |
11.2.4.Copolyester Ether |
11.3. Size Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.500-1000 ml |
11.3.2.250-500 ml |
11.3.3.Up to 250 ml |
11.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Blood Storage |
11.4.2.Blood Transfusions |
11.4.3.Medications |
11.4.4.Electrolyte Imbalance |
11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) IV Bags Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Single Chamber IV Bags |
12.1.2.Multi-Chamber IV Bags |
12.2. Material Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Polypropylene |
12.2.2.Polyvinylchloride (PVC) |
12.2.3.Ethylene Vinyl Acetate |
12.2.4.Copolyester Ether |
12.3. Size Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.500-1000 ml |
12.3.2.250-500 ml |
12.3.3.Up to 250 ml |
12.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Blood Storage |
12.4.2.Blood Transfusions |
12.4.3.Medications |
12.4.4.Electrolyte Imbalance |
12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) IV Bags Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Single Chamber IV Bags |
13.1.2.Multi-Chamber IV Bags |
13.2. Material Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Polypropylene |
13.2.2.Polyvinylchloride (PVC) |
13.2.3.Ethylene Vinyl Acetate |
13.2.4.Copolyester Ether |
13.3. Size Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.500-1000 ml |
13.3.2.250-500 ml |
13.3.3.Up to 250 ml |
13.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Blood Storage |
13.4.2.Blood Transfusions |
13.4.3.Medications |
13.4.4.Electrolyte Imbalance |
13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America IV Bags Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Single Chamber IV Bags |
14.1.2.Multi-Chamber IV Bags |
14.2. Material Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Polypropylene |
14.2.2.Polyvinylchloride (PVC) |
14.2.3.Ethylene Vinyl Acetate |
14.2.4.Copolyester Ether |
14.3. Size Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.500-1000 ml |
14.3.2.250-500 ml |
14.3.3.Up to 250 ml |
14.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Blood Storage |
14.4.2.Blood Transfusions |
14.4.3.Medications |
14.4.4.Electrolyte Imbalance |
14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1. ICU Medical, Inc. (U.S.) |
15.2.2. Medline Industries, Inc. (U.S.) |
15.2.3. Kraton Corporation (U.S.) |
15.2.4. Braun Melsungen AG (Germany) |
15.2.5. Hospira Inc. (Pfizer, Inc.) (U.S.) |
15.2.6. Otsuka Pharmaceutical Co. Ltd. (Japan) |
15.2.7. Haemotronic S.p.A (Italy) |
15.2.8. Wipak Group (Germany) |
15.2.9. Fresenius SE & Co. KGaA (Germany) |
15.2.10. Polycine GmbH (Germany) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players